Melanin synthesis is regulated by melanocyte specific enzymes and related transcription factors. β-carboline alkaloids including harmaline and harmalol are widely distributed in the environment including several plant families and alcoholic beverages. Presently, melanin content and tyrosinase activity were increased in melanoma cells by harmaline and harmalol in concentration-and time-dependent manners. Increased protein levels of tyrosinase, tyrosinase-related protein-1 (TRP-1), and TRP-2 were also evident. In addition, immunofluorescence and Western blot analyses revealed harmaline and harmalol increased cAMP response element binding protein phosphorylation and microphthalmia-associated transcription factor expression. In addition to studying the signaling that leads to melanogenesis, roles of the p38 MAPK pathways by the harmaline and harmalol were investigated. Harmaline and harmalol induced time-dependent phosphorylation of p38 MAPK. Harmaline and harmalol stimulated melanin synthesis and tyrosinase activity, as well as expression of tyrosinase and TRP-1 and TRP-2 indicating that these harmaline and harmalol induce melanogenesis through p38 MAPK signaling. [BMB reports 2010; 43(12): 824-829]
INTRODUCTION
The synthesis of melanin pigments or melanogenesis has many important physiological functions that include photoprotection of the human skin from ultraviolet (UV) irradiation (1). Melanogenesis is a complex pathway involving melanin synthesis, melanin transport, and melanosome release (2). Melanin synthesis is stimulated by various effects such as α-melanocyte-stimulating hormone (α-MSH); cyclic AMP (cAMP) elevating agents including forskolin, glycyrrhizin, and isobutylmethylxanthine; UV-B radiation; and the placental total lipid fraction (3-5). In addition, melanin synthesis occurs in melanocytes and melanoma cells through an enzymatic process catalyzed by tryrosinase, tyrosinase related protein-1 (TRP-1), and tyrosinase related protein-2 (TRP-2), which converts tyrosine to 3,4-dihydroxyphenylalanine (DOPA) and catalyzes the oxidation of DOPA into DOPAquinone (6). Dopaquinone is converted to dopachrome that is in turn converted to dihyroxyindole or dihydroxyindole-2-carbxylic acid (DHICA) to form eumelanin. The cascade of enzymatic reactions in melanin synthesis is related in tyrosinase, TRP-1 (dopachrome tautomerase) and TRP-2 (DHICA oxidase) (7).
Microphthalmia-associated transcription factor (MITF) is the most important transcription factor in the regulation of tyrosinase and expression of the genes for TRP-1 and TRP-2, as tyrosinase, TRP-1, and TRP-2 harbor the MITF binding site, thereby leading to the regulation of activation of melanocyte differentiation (8). cAMP response element binding protein (CREB) is also one of the major transcription factors of MITF and, thus, plays a central role in melanogenesis (9). The CREB binding site is present in the MITF promoter region; as a consequence, CREB binds to and activates the MITF promoter, which leads to the indirect activation of melanogenesis (10).
Mitogen-activated protein kinases (MAPKs) are a highly conserved family of protein serine/threonine kinases that include extracellularly responsive kinases (ERK1/2), c-jun N-terminal or stress-regulated protein kinases (JNK/SAPK), and p38 MAPKs. They are involved in a diversity of cellular activities and have an important regulatory role in melanogenesis (11). p38 MAPK activation is related to an increase in melanin synthesis and is involved in the expression of melanogenesis related molecules (12). In addition, p38 MAPK activation is involved in α-MSHinduced melanogeneis, such as activation of MITF expression and activation of tyrosinase transcription (13), whereas the extracellular signal-regulated kinase (ERK)1/2 and c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) pathways are related with the down-regulation of melanogenesis (14). Accordingly, ERK signaling inactivation or p38 MAPK signaling activation stimulates melanogenesis by increasing MITF expre-http://bmbreports.org BMB reports and harmalol (5-20 μM) were analyzed for their melanin content. The melanin content was corrected based on the amount of protein concentration. α-MSH (1 μM) served as the positive control for 72 h. Cells treated with harmaline (5 μM) and harmalol (20 μM) for determined times were analyzed for their melanin content (B) and tyrosinase activity (C). α-MSH (1 μM) was the positive control for 72 h. The cellular tyrosinase activity was determined and is reported as a percentage reported relative to that in the control cells. Values are means ± SE of three independent experiments. *P ＜ 0.05 versus untreated control. In situ tyrosinase activity determined by incubation of cells in L-DOPA. Images were captured under identical conditions using phase contrast microscopy and are representative of three independent experiments (D). (E) Cells were incubated for determined times with harmaline and harmalol. The cellular extracts were then subjected to Western blot analysis using tyrosinase, TRP-1, and TRP-2 antibody. Equal protein loading was confirmed by α-tubulin expression. Numbers at the bottom are expressed as relative intensity of band (fold of control) estimated by using ImageQuant TL software.
ssion and tyrosinase activity. β-carbolines are component of some medicinal plants, such as Passiflora edulis, Passiflora incarnate and Peganum harmala. These plants have been used for anti-jaundice, anti-lumbago and anti-inflammation agent in oriental medicine. Recently, the mechanism responsible for traditional herbal medicines variable effects has not been fully clarified yet. β-carboline alkaloids are widely distributed in environments including several plant families, well-cooked foods, tobacco smoke, and alcoholic beverages (15). Additionally, they are endogenous in mammalian tissues. β-carboline alkaloids have a reported wide range of pharmacological, neurophysiologic, and biochemical actions (16, 17) ; are both mutagenic and carcinogenic (18); and act as a neurotoxins in some neurodegenerative diseases. In contrast, the β-carboline alkaloids harmaline and harmalol (Fig. 1A) inhibit monoamine oxidase and do not induce neurotoxicity (19). In addition, β-carbolines possess effective antioxidant and radical scavenging properties, protect from oxidative neuronal damage, and inhibit the ion-mediated cytotoxic effect of 1-methyl-4-phenylpyridinium (MMP + ) and cytotoxic effects on tumor cells (17). Furthermore, plants containing β-carboline alkaloids have long been used as traditional medicines for the treatment of various diseases including cancer, jaundice, malaria, and asthma (19, 20) . Recently, it was reported that β-carbolines induce apoptosis by caspase-8 activation in carcinoma cells and function as an anti-inflammatory compound that suppresses lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) through the nuclear factor (NF)-kappaB and I-kappaB kinase (IKK) signaling pathways (21, 22) . However, it is not known whether β-carbolines directly contribute to melanogenesis dysfunction. Therefore, using mouse B16F10 melanoma cells, we attempted to determine the effects and mechanisms of the β-carbolines harmaline and harmalol on melanogenesis, specifically whether these β-carbolines are affected by melanogenesis, and characterized the signal transduction pathway involved.
RESULTS

Harmaline and harmalol increase cellular melanin content in B16F10 melanoma cells
Cells were treated with various concentrations of harmaline and harmalol for 72 h. Cellular melanin content was assessed by determination of intracellular melanin, expressed as a percentage related to the total protein. As shown in Fig. 1A , harmaline and harmalol treatment increased the melanin content, consistent with enhanced melanin synthesis in response to serial concentrations of harmaline and harmalol. Of note, augmentation of intracellular melanin content by harmaline appeared more sustained than that evoked by harmalol. The cell growth effect of harmaline and harmalol were investigated in cells treated with various concentrations (1-20 μM) of harmaline and harmalol for 72 h (data not shown). Cell growth arrest was induced by 10 μM harmaline and 20 μM harmalol, while treatment with either β-carboline alkaloid did not result in cell necrosis and detachment from the culture plates (data not shown).
Harmaline and harmalol induce tyrosinase activity and melanogenesis-related proteins
To verify if the effect of harmaline and harmalol on melanin synthesis and tyrosinase activity occurred in a time-dependent
